Sanofi, Regeneron Pharma bag USFDA nod for Kevzara to treat polymyalgia rheumatica Ruchika Sharma2 March 2023 1:15 PM ISTPolymyalgia rheumatica often initially presents with pain and stiffness around the neck, shoulder and hip area and symptoms include fatigue, low-grade...
WHO suggests Roche, Sanofi arthritis drugs to cut death risk in COVID patients Farhat Nasim8 July 2021 12:30 PM ISTA WHO group evaluating therapies concluded treating severe and critical COVID patients with arthritis drugs Actemra from Roche and Kevzara from Sanofi...
Roche, Sanofi arthritis drugs Actemra, Kevzara respectively reduce death rates among sickest COVID patients: Study Ruchika Sharma9 Jan 2021 9:00 AM ISTLondon: Treating critically ill COVID-19 patients with Roche's Actemra or Sanofi's Kevzara arthritis drugs significantly improves survival rates and...
Sanofi halts trial of Covid-19 drug Kevzara after tests prove inconclusive Medical Dialogues Team21 Sept 2020 12:30 PM ISTPARIS: French pharma giant Sanofi said Tuesday that international Phase 3 clinical tests of its Kevzara drug for serious Covid-19 cases had...
Sanofi COVID-19 drug Kevzara fails test, clinical trails halted Ruchika Sharma2 Sept 2020 5:12 PM ISTParis: In a major setback, French drugmaker Sanofi, recently announced that the company has halted the clinical trials of its COVID-19 drug Kevzara...
Sanofi, Regeneron arthritis drug Kevzara fails COVID-19 study Ruchika Sharma4 July 2020 10:00 AM ISTParis: Sanofi and Regeneron Pharmaceuticals, Inc. have announced that the U.S. Phase 3 trial of Kevzara (sarilumab) 400 mg in COVID-19 patients...
Covid-19: Varying Results of 2 different arthritis drug trials complicate search for cure MD Bureau28 April 2020 10:18 PM ISTFurther studies will be required to know if the drug can prove to be effective against the disease, according to researchers.
155 drugs and 79 vaccines in development to fight coronavirus Ruchika Sharma22 April 2020 4:23 PM ISTVienna: It seems as if the test tubes of this world currently only exist for coronaviruses – pharmaceutical and biotech companies, university...
